« Back
Home /
Tunicamycin

Tunicamycin

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer Head & Neck Cancer Gastric Cancer
Type	Inhibitors
Specific against	other
Amount	2 mg
Item no.	HY-A0098-2mg
Targets	Bacterial; Fungal; Influenza Virus; Antibiotic
CASRN	11089-65-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Tunicamycin is a mixture of homologous nucleoside antibiotic that inhibits N-linked glycosylation and blocks GlcNAc phosphotransferase (GPT). Tunicamycin causes accumulation of unfolded proteins in cell endoplasmic reticulum (ER) and induces ER stress, and causes blocking of DNA synthesis and cell cycle arrest in G1 phase. Tunicamycin inhibits gram-positive bacteria, yeasts, fungi, and viruses and has anti-cancer activity[1][2][3].Tunicamycin increases exosome release in cervical cancer cells[4].
StorageTemperature	-20°C, 3 years (Powder)
Shipping	Blue Ice
Manufacturers Applications	COVID-19-anti-virus
MolecularWeight	844.94 (n=10)
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer; Infection; Inflammation/Immunology
Solubility	DMSO : 33.33 mg/mL (ultrasonic)\|H2O : 1.5 mg/mL (ultrasonic)
Manufacturers Target	Antibiotic; Bacterial; Fungal; Influenza Virus
Pathway	Anti-infection
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-A0098-2mg-safety-datasheet.pdf